Montvale, NJ - - April 4, 2007 – Memory Pharmaceuticals Corp. (NASDAQ: MEMY) today announced that Jim Sulat, President and Chief Executive Officer, will provide a company update at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference on Wednesday, April 11, 2007, at 1:20 p.m. Eastern Time at the Millennium Broadway Hotel in New York City.
Interested parties may access a live audio webcast of the presentations by visiting the
“Investors” section of Memory Pharmaceuticals’ website at
http://www.memorypharma.com. Archived versions of the webcast will be available
at the same location for one week following the presentation.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing
innovative drugs for the treatment of debilitating CNS disorders such as
Alzheimer's disease, schizophrenia, depression and bipolar disorder. For
additional information, please visit our website at
http://www.memorypharma.com.
Safe Harbor Statement
sh
SOURCE Memory Pharmaceuticals Corp.
http://www.memorypharma.com/
